Literature DB >> 29945815

Natural course of new-onset urticaria: Results of a 10-year follow-up, nationwide, population-based study.

Sang Jun Eun1, Jin Yong Lee2, Do-Yeop Kim3, Hyun-Sun Yoon4.   

Abstract

BACKGROUND: Previous epidemiologic studies of the natural course of urticaria mainly focused on chronic spontaneous urticaria and were conducted at hospitals. The natural course of new-onset urticaria in the general population is unknown.
METHODS: Patients with new-onset urticaria were identified from the National Health Insurance Service-National Sample Cohort data. Patients who had at least one visit for urticaria in 2002 and 2003 were excluded and the study cohort consisted of 1,027,620 subjects with no history of urticaria. We analyzed cumulative incidences of urticaria, chronic urticaria, and chronic urticaria remission using the life table estimation method from 2004 to 2013. Their association with related factors was analyzed using the Cox proportional hazards analysis.
RESULTS: From 2004 to 2013, a total of 49,129 patients with new-onset urticaria were identified. The 10-year cumulative incidence rate of urticaria for the general population was 4.9% and that of chronic urticaria among patients with new-onset urticaria was 7.8%. Remission rates of chronic urticaria were 52.6% at 1 year and 88.9% at 5 years. Age, sex, residential area, and autoimmune thyroid disease were significantly associated with urticaria or chronic urticaria, but not with chronic urticaria remission, after adjusting for covariates. Female individuals were more likely to have new-onset urticaria but less likely to develop chronic urticaria compared with male individuals.
CONCLUSIONS: During the 10-year follow-up period, only a small proportion of patients with new-onset urticaria developed chronic urticaria. Remission was achieved in the majority of patients with chronic urticaria regardless of demographic characteristics or accompanying thyroid disease.
Copyright © 2018 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic urticaria; National health insurance Service–National sample cohort; Natural course; Remission; Urticaria

Mesh:

Year:  2018        PMID: 29945815     DOI: 10.1016/j.alit.2018.05.011

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  12 in total

1.  Advances in drug allergy, urticaria, angioedema, and anaphylaxis in 2018.

Authors:  Rachel L Miller; Maria Shtessel; Lacey B Robinson; Aleena Banerji
Journal:  J Allergy Clin Immunol       Date:  2019-06-24       Impact factor: 10.793

Review 2.  Urticaria.

Authors:  Pavel Kolkhir; Ana M Giménez-Arnau; Kanokvalai Kulthanan; Jonny Peter; Martin Metz; Marcus Maurer
Journal:  Nat Rev Dis Primers       Date:  2022-09-15       Impact factor: 65.038

3.  Prospective analysis of clinical evolution in chronic urticaria: Persistence, remission, recurrence, and pruritus alone.

Authors:  Jorge Sánchez; Leidy Álvarez; Ricardo Cardona
Journal:  World Allergy Organ J       Date:  2022-10-08       Impact factor: 5.516

Review 4.  The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management.

Authors:  Woo Jung Song; Mira Choi; Dong Hun Lee; Jae Woo Kwon; Gun Woo Kim; Myung Hwa Kim; Mi Ae Kim; Min Hye Kim; Byung Keun Kim; Sujeong Kim; Joung Soo Kim; Jung Eun Kim; Ju Young Kim; Joo Hee Kim; Hyun Jung Kim; Hye One Kim; Hyo Bin Kim; Joo Young Roh; Kyung Hee Park; Kui Young Park; Han Ki Park; Hyunsun Park; Jung Min Bae; Ji Yeon Byun; Dae Jin Song; Young Min Ahn; Seung Eun Lee; Young Bok Lee; Joong Sun Lee; Ji Hyun Lee; Kyung Hwan Lim; Young Min Ye; Yoon Seok Chang; You Hoon Jeon; Jiehyun Jeon; Mihn Sook Jue; Sun Hee Choi; Jeong Hee Choi; Gyu Young Hur; Young Min Park; Dae Hyun Lim; Sang Woong Youn
Journal:  Allergy Asthma Immunol Res       Date:  2020-07       Impact factor: 5.764

5.  Cupping for patients with chronic urticaria: A systematic review protocol.

Authors:  Xianjun Xiao; Yunzhou Shi; Leixiao Zhang; Wei Cao; Ying Liu; Siyuan Zhou; Mingling Chen; Qianhua Zheng; Ying Li
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

6.  Medication Requirements for Disease Control Predict the Prognosis of Chronic Urticaria.

Authors:  Jeong Hee Choi
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

7.  Acupoint injection of Bacillus Calmette-Guerin polysaccharide nucleic acid for patients with chronic urticaria: A protocol for systematic review.

Authors:  Wei Cao; Xianjun Xiao; Leixiao Zhang; Lu Wang; Qianhua Zheng; Siyuan Zhou; Ying Liu; Yue Cao; Mingling Chen; Chunxiao Li; Ying Li
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

8.  The impact of COVID-19 pandemic on the management of patients with chronic urticaria: An observational two-center study from Turkey.

Authors:  Yasemin Erdem; Algün Polat Ekinci; Ilknur Kivanc Altunay; Onur Sivaz; Sena Inal; Mehmet Onur Gokalp; Gizem Pehlivan; Esen Özkaya
Journal:  Dermatol Ther       Date:  2020-12-19       Impact factor: 3.858

9.  Multi-center study for acupuncture combined with Chinese medicine in the treatment of chronic spontaneous urticaria based on the theory of taking shu-stream points when the disease is aggravated.

Authors:  Yuesi Qin; Jing Guo; Pan Song; Tianshu Hou; Yan He; Ming Han; Qianying Yu; Wenxia Lin; Mingling Chen; Hong Su
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

10.  Compound glycyrrhizin combined with antihistamines for chronic urticaria: A protocol for systematic review and meta analysis.

Authors:  Wei Cao; Xianjun Xiao; Leixiao Zhang; Ying Liu; Lu Wang; Zihao Zou; Yue Cao; Chunxiao Li; Qianhua Zheng; Siyuan Zhou; Ying Li
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.